sergliflozin [Ligand Id: 4587] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL450044 (Etabonate de sergliflozine, Etabonato de sergliflozina, GW-869682X, GW869682X, GW-869683X, Sergliflozin, Sergliflozin a, Sergliflozin etabonate)
  • Low affinity sodium-glucose cotransporter in Human [ChEMBL: CHEMBL1770047] [GtoPdb: 917] [UniProtKB: Q9NY91]
There should be some charts here, you may need to enable JavaScript!
  • Sodium/glucose cotransporter 1 in Human [ChEMBL: CHEMBL4979] [GtoPdb: 915] [UniProtKB: P13866]
There should be some charts here, you may need to enable JavaScript!
  • Sodium/glucose cotransporter 2 in Human [ChEMBL: CHEMBL3884] [GtoPdb: 916] [UniProtKB: P31639]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
Low affinity sodium-glucose cotransporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1770047] [GtoPdb: 917] [UniProtKB: Q9NY91]
ChEMBL Inhibition of human SGLT2 expressed in CHO cells assessed as [14C]AMG uptake after 45 mins B 6.59 pIC50 260 nM IC50 Bioorg Med Chem (2011) 19: 5334-5341 [PMID:21873071]
Sodium/glucose cotransporter 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4979] [GtoPdb: 915] [UniProtKB: P13866]
GtoPdb - - 5.1 pKi 7943 nM Ki J Pharmacol Exp Ther (2007) 320: 323-30 [PMID:17050778]
ChEMBL Inhibition of human SGLT1 expressed in CHO-K1 cells B 5.12 pKi 7540 nM Ki J Med Chem (2022) 65: 10848-10881 [PMID:35924548]
ChEMBL Inhibition of human SGLT1 expressed in CHO cells assessed as [14C]AMG uptake after 45 mins B 4.66 pIC50 22000 nM IC50 Bioorg Med Chem (2011) 19: 5334-5341 [PMID:21873071]
ChEMBL Inhibition of human SGLT1 expressed in CHO-K1 cells by [14C]AMG uptake assay B 4.66 pIC50 22000 nM IC50 Bioorg Med Chem (2012) 20: 4117-4127 [PMID:22652255]
ChEMBL Inhibition of SGLT1 (unknown origin) B 5.68 pIC50 2100 nM IC50 J Med Chem (2023) 66: 12536-12543 [PMID:37608596]
Sodium/glucose cotransporter 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3884] [GtoPdb: 916] [UniProtKB: P31639]
GtoPdb - - 6.8 pKi 158 nM Ki J Pharmacol Exp Ther (2007) 320: 323-30 [PMID:17050778]
ChEMBL Inhibition of human SGLT2 expressed in CHO-K1 cells B 6.82 pKi 151 nM Ki J Med Chem (2022) 65: 10848-10881 [PMID:35924548]
ChEMBL Inhibition of human SGLT2 expressed in CHO-K1 cells by [14C]AMG uptake assay B 6.59 pIC50 260 nM IC50 Bioorg Med Chem (2012) 20: 4117-4127 [PMID:22652255]
ChEMBL Inhibition of SGLT2 (unknown origin) B 8.12 pIC50 7.5 nM IC50 J Med Chem (2023) 66: 12536-12543 [PMID:37608596]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]